etoposide has been researched along with Neoplasms, Squamous Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bigda, J; Czetyrbok, K; Filipska, M; Jassem, J; Skrzypski, M; Stasiłojć, G; Stokowy, T; Supernat, A; Żaczek, AJ | 1 |
1 other study(ies) available for etoposide and Neoplasms, Squamous Cell
Article | Year |
---|---|
MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Etoposide; Gene Expression Profiling; Humans; Immune Evasion; Lung Neoplasms; MicroRNAs; Neoplasm Invasiveness; Neoplasms, Squamous Cell | 2018 |